NeOnc claims that its novel intranasal delivery platform will be able to bypass the blood-brain barrier and better target ...

Trevi Therapeutics has finished enrolling subjects in a trial of investigational Haduvio for treating chronic cough in IPF ...

Early results from the company’s single-arm trial saw the therapy able to partially repair the chemical responsible for ...

The Phase II trial comes as the US Food and Drug Administration grants an investigational new drug application for cannabis ...

In an anonymous post in the BMJ, the author claims that words relating to DEI could lead to grants being taken away.

The CoTikiS trial’s 10-week results from the 50-week ulcerative colitis trial saw as an endoscopic improvement rate of 32% in ...

Sanofi and Teva Pharmaceuticals have reported new outcomes from the Phase IIb RELIEVE UCCD trial of duvakitug.

Ensho has presented additional data supporting NSHO-101, also referred to as EA1080, as an oral one-time-a-day treatment for ...

NHS data showed a 40% increase in the detection of blood-borne infections, including HIV, during a pilot scheme in 2023.

Solid Biosciences’ gene therapy candidate for patients with DMD has elicited a 110% expression of the microdystrophin gene.

Novadip's bone graft material NVDX3 has seen all patients achieve bone fracture union in a 12-month Phase Ib/IIa ...

Vyne Therapeutics has dosed the first participant in a Phase Ib trial of VYN202, an oral treatment for moderate-to-severe ...